Preclinical Studies

TORONTO–(BUSINESS WIRE)–Oct 31, 2018–FSD Pharma Inc. (“ FSD Pharma ” or “ FSD ”) (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) today announced the launch of a pilot clinical study in Pittsburgh, Pennsylvania, by its strategic RD partner, SciCann Therapeutics (“ SciCann ”). The study is designed to test the safety and efficacy of SciCann’s proprietary […]

by

Earnest Partners Llc decreased Mednax Inc (MD) stake by 2.3% reported in 2018Q4 SEC filing. Earnest Partners Llc sold 44,607 shares as Mednax Inc (MD)’s stock declined 18.39%. The Earnest Partners Llc holds 1.90 million shares with $62.61M value, down from 1.94M last quarter. Mednax Inc now has $2.23 billion valuation. The stock decreased 2.53% […]

by

InVivo Therapeutics Holdings Corp. (NVIV) formed double bottom with $1.42 target or 9.00% below today’s $1.56 share price. InVivo Therapeutics Holdings Corp. (NVIV) has $14.53 million valuation. The stock increased 1.30% or $0.02 during the last trading session, reaching $1.56. About 241 shares traded. InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) has declined 87.15% since April 15, […]

by

Chase Investment Counsel Corp decreased SsC Technologis Hldgs Inc (SSNC) stake by 79.6% reported in 2018Q4 SEC filing. Chase Investment Counsel Corp sold 75,225 shares as SsC Technologis Hldgs Inc (SSNC)’s stock rose 28.20%. The Chase Investment Counsel Corp holds 19,274 shares with $869,000 value, down from 94,499 last quarter. SsC Technologis Hldgs Inc now […]

by

Pathfinder Bancorp Inc (NASDAQ:PBHC) is expected to pay $0.06 on May 10, 2019. (NASDAQ:PBHC) shareholders before Apr 17, 2019 will receive the $0.06 dividend. Pathfinder Bancorp Inc’s current price of $12.95 translates into 0.46% yield. Pathfinder Bancorp Inc’s dividend has Apr 18, 2019 as record date. Mar 29, 2019 is the announcement. It closed at […]

BXCL501 Pharmacokinetic (Bioavailability) and safety study on track to read out in second quarter 2019; initiation of Phase 2/3 Registration Trial expected in second half 2019 Human Proof of Concept established in multiple indications for BXCL501, high response rates observed with IV Dex in Schizophrenia, Alzheimer’s Disease / Dementia and Opioid Withdrawal Patients Clinical partnership […]

June 12 (UPI) — Rather than invasive weight loss procedures, a “surgery in a pill” has shown promise for treatment of type 2 diabetes in obese patients, according to a study. Researchers at Brigham and Women’s Hospital in Boston conducted a preclinical study with rats in which an oral agent would allow food to pass […]

It can be relatively easy to experience medical benefits from cannabis. A puff or two of tetrahydrocannabinol (THC)-rich flower can do the trick for a lot of people. Smoking marijuana, however, is not the be-all and end-all of cannabis therapeutics. There are many ways to experience the medical benefits of cannabis, and some of them are […]

Feeding only on sugar, the yeast are an easy and cheap way to produce pure cannabinoids that today are costly to extract from the buds of the marijuana plant, Cannabis sativa. “For the consumer, the benefits are high-quality, low-cost CBD and THC: you get exactly what you want from yeast,” said Jay Keasling, a UC […]

by

Severe widespread flooding from storms across the U.S. illustrate flood dangers Recent severe flood damage in Texas, Florida and Puerto Rico is a grave reminder to prepare for possible flood hazards – particularly as climate scientists predict a “La Niña” weather pattern this winter that could mean more flooding from rain-laden storms across King County. […]

by

Posted in: Medical Research News | Medical Condition News Tags: Bioengineering, Brain, Brain Cancer, Brain Tumor, Cancer, Clinical Trial, Diabetes, DNA, DNA Damage, Drugs, Endocrine, Gene, Genes, Glioma, Gliomas, Health and Human Services, Imaging, Kidney, Medicine, Mutation, Nervous System, Neurological Disease, Neurosurgery, Nutrition, Obesity, pH, Preclinical, Protein, Radiation Exposure, Radiation Therapy, Research, Stroke, Tumor … […]

by

Posted in: Medical Science News Tags: Brain, Cardiometabolic, Central Nervous System, Gene, Gene Silencing, Genes, Genetic, Infectious Diseases, Liver, Nervous System, Neurodegenerative Diseases, Pharmaceuticals, Physiology, Preclinical, Research, RNA, RNA Interference, RNAi, RNAi Therapeutics, Sclerosis, siRNA, therapeutics, Translation … read more at: https://www.news-medical.net/news/20180508/Alnylam-achieves-delivery-of-novel-siRNAs-conjugates-to-the-central-nervous-system.aspx

by